Literature DB >> 28224268

Serum serotonin, leptin, and adiponectin changes in women with postpartum depression: controlled study.

Gazi Yildiz1, Mehmet Baki Senturk2, Pinar Yildiz1, Yusuf Cakmak3, Mehmet Sukru Budak4, Erbil Cakar5.   

Abstract

PURPOSE: Postpartum depression (PPD) affects nearly 10% of mothers after delivery and has many serious results. Although many factors associated with PPD, the etiology, and pathophysiology of PPD are not known completely. The relationship between serum serotonin concentration and depression is well known, but there are no enough data regarding the serum change of leptin and adiponectin. The aims of this study are to research the level of serum serotonin, leptin,s and adiponectin concentrations in women with PPD.
MATERIALS AND METHODS: A controlled trial has been conducted in three centers. Two hundred and forty four women were evaluated at postpartum day 10 with the Edinburgh Postnatal Depression Scale (EPDD). Venous blood samples were collected and serotonin, and leptin and adiponectin levels were studied using human enzyme-linked immunosorbent assay. Mann-Whitney U test was used for comparison of serum levels of serotonin, leptin, and adiponectin between women with PPD and without. A p value of <0.05 was considered significant.
RESULTS: PPD was detected in 70 postpartum women. The mean serum serotonin level was significantly lower in the group with PPD (p = 0.001), while mean serum adiponectin level was higher (p = 0.001). The mean serum leptin level was not different (p = 0.133).
CONCLUSIONS: The serum adiponectin and leptin levels were high in women with PPD. This could play important role in the pathophysiology of PPD. Elevation of serum levels also may play antidepressant role against PPD, especially the early postpartum period.

Entities:  

Keywords:  Adiponectin; Leptin; Postpartum; Postpartum depression

Mesh:

Substances:

Year:  2017        PMID: 28224268     DOI: 10.1007/s00404-017-4313-0

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  6 in total

1.  Roles of Inflammation and Depression in the Development of Gestational Diabetes.

Authors:  Thalia K Robakis; Linn Aasly; Katherine Ellie Williams; Claire Clark; Natalie Rasgon
Journal:  Curr Behav Neurosci Rep       Date:  2017-10-28

2.  Seasonal affective disorder and seasonal changes in weight and sleep duration are inversely associated with plasma adiponectin levels.

Authors:  Faisal Akram; Claudia Gragnoli; Uttam K Raheja; Soren Snitker; Christopher A Lowry; Kelly A Stearns-Yoder; Andrew J Hoisington; Lisa A Brenner; Erika Saunders; John W Stiller; Kathleen A Ryan; Kelly J Rohan; Braxton D Mitchell; Teodor T Postolache
Journal:  J Psychiatr Res       Date:  2020-01-02       Impact factor: 4.791

3.  Patient-controlled intravenous tramadol versus patient-controlled intravenous hydromorphone for analgesia after secondary cesarean delivery: a randomized controlled trial to compare analgesic, anti-anxiety and anti-depression effects.

Authors:  Guangyou Duan; Xiaohang Bao; Guiying Yang; Jing Peng; Zhuoxi Wu; Peng Zhao; Zhiyi Zuo; Hong Li
Journal:  J Pain Res       Date:  2018-12-18       Impact factor: 3.133

4.  Assessment of major mental disorders in a German peripartum cardiomyopathy cohort.

Authors:  Tobias J Pfeffer; Julian Herrmann; Dominik Berliner; Tobias König; Lotta Winter; Melanie Ricke-Hoch; Evgeni Ponimaskin; Sven Schuchardt; Thomas Thum; Denise Hilfiker-Kleiner; Johann Bauersachs; Kai G Kahl
Journal:  ESC Heart Fail       Date:  2020-09-10

5.  Biological reflect of Adiponectin hormone in postpartum marital satisfaction and depression scores.

Authors:  Fattaneh Pahlavan; Anoshirvan Kazemnejad; Fatemeh Razavinia; Seyedeh Razieh Fazeli Daryasari; Najmeh Tahranian
Journal:  BMC Pregnancy Childbirth       Date:  2020-09-11       Impact factor: 3.007

6.  5HTTLPR polymorphism and postpartum depression risk: A meta-analysis.

Authors:  Jianming Li; Yongjun Chen; Qin Xiang; Ju Xiang; Yonghong Tang; Liang Tang
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.